Targeting the Calcium Signalling Machinery in Cancer

Jason I E Bruce1, Andrew D James2

  • 1Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK.

Cancers
|August 23, 2020
PubMed

Insights

Targeting calcium signaling pathways offers a novel therapeutic strategy for cancer treatment. This approach addresses key cancer hallmarks like proliferation and migration, presenting a promising avenue for drug development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Calcium Signaling

Background:

  • Cancer involves uncontrolled cell proliferation, evasion of cell death, and metastasis.
  • Cytosolic calcium ions (Ca2+) play a critical role in these cancer-associated cellular processes.
  • Current cancer therapies do not extensively target the Ca2+ signaling machinery.

Purpose of the Study:

  • To review emerging evidence on targeting Ca2+ signaling components as a cancer treatment strategy.
  • To highlight the therapeutic potential of modulating Ca2+ pathways in oncology.

Main Methods:

  • Literature review of studies investigating the role of Ca2+ in cancer.
  • Analysis of emerging therapeutic strategies targeting Ca2+ signaling pathways.

Main Results:

  • Ca2+ signaling is integral to cancer cell proliferation, survival, migration, invasion, and vascularization.
  • Modulating specific Ca2+ channels and pumps shows potential in preclinical cancer models.
  • Targeting Ca2+ machinery represents an underexplored therapeutic avenue.

Conclusions:

  • Targeting cytosolic Ca2+ signaling is a promising and novel strategy for cancer therapy.
  • Further research and clinical trials are warranted to develop Ca2+-targeting cancer drugs.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Feedback Regulation of Calcium Concentration01:27

Feedback Regulation of Calcium Concentration

Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
3.8K